Raquel Pedrosa Bezerra

Dr. Raquel Pedrosa Bezerra

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Chemosphere
Verified
Journal Article
Closed access
RMRebeca Gonçalves de Melo
Rebeca Gonçalves de Melo
AAAlexsandra Frazão de Andrade
Alexsandra Frazão de Andrade
RBRaquel Pedrosa Bezerra
Raquel Pedrosa Bezerra
DCDominick Spindola Correia
Dominick Spindola Correia
VSVanessa Cristina de Souza
Vanessa Cristina de Souza
APAna Lúcia Figueiredo Porto
Ana Lúcia Figueiredo Porto

17 June 2019 in Journal of Applied Phycology
Verified
Journal Article
Closed access
PDF file
RMRebeca Gonçalves de Melo
Rebeca Gonçalves de Melo
AAAlexsandra Frazão de Andrade
Alexsandra Frazão de Andrade
RBRaquel Pedrosa Bezerra
Raquel Pedrosa Bezerra
DMDaniela de Araújo Viana Marques
Daniela de Araújo Viana Marques
VSValdemiro Amaro da Silva
Valdemiro Amaro da Silva
APAna Lucia Figueiredo Porto
Ana Lucia Figueiredo Porto

1 October 2021 in ACS Chemical Biology
Verified
Journal Article
Closed access
MSMaria Rafaele Oliveira Bezerra da Silva
Maria Rafaele Oliveira Bezerra da Silva
GSGisele M. da Silva
Gisele M. da Silva
ASAmannda L. F. da Silva
Amannda L. F. da Silva
LLLuiza R. A. de Lima
Luiza R. A. de Lima
RBRaquel Pedrosa Bezerra
Raquel Pedrosa Bezerra
DMDaniela de A. V. Marques
Daniela de A. V. Marques

1 December 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
PBPriscila Danielly Santos de Barros
Priscila Danielly Santos de Barros
PSPablo Eugênio Costa e Silva
Pablo Eugênio Costa e Silva
TNThiago Pajeú Nascimento
Thiago Pajeú Nascimento
RCRomero Marcos Pedrosa Brandão Costa
Romero Marcos Pedrosa Brandão Costa
RBRaquel Pedrosa Bezerra
Raquel Pedrosa Bezerra
APAna Lúcia Figueiredo Porto
Ana Lúcia Figueiredo Porto

5 January 2022 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
AAAlexsandra Frazão de Andrade
Alexsandra Frazão de Andrade
APAna Lúcia Figueiredo Porto
Ana Lúcia Figueiredo Porto
RBRaquel Pedrosa Bezerra
Raquel Pedrosa Bezerra

17 May 2019 in Microbiologyopen
Verified
Journal Article
Open access
PDF file
TPThamara F. Procópio
Thamara F. Procópio
MMMaiara C. Moura
Maiara C. Moura
EBElinaldo F. L. Bento
Elinaldo F. L. Bento
TSTatiana Soares
Tatiana Soares
LCLuana C. B. B. Coelho
Luana C. B. B. Coelho
Thiago Henrique NapoleãoThiago Henrique Napoleão
Thiago Henrique Napoleão
This work aimed to evaluate the effects of CasuL on growth and viability of 15 mastitis isolates from cows and goats, to determine the synergistic potential between CasuL and antibiotics, and to investigate the effects on bacterial ultrastructure and antibiofilm activity. The lectin inhibited the growth of Staphylococcus isolates from either bovine (Ssp6PD and Sa) or caprine (Ssp5D and Ssp01) mastitis. The minimal inhibitory concentrations were ranged from 3.75 to 15 µg/ml. Synergistic effect was observed for CasuL‐tetracycline against Sa and Ssp6PD and CasuL‐ampicillin against Ssp01. No structural damage was observed under the scanning electron microscope in CasuL treatments. Flow cytometry analysis using thiazol orange and propidium iodide demonstrated that CasuL was unable to reduce the cell viability of the isolates tested. At sub‐inhibitory concentrations, CasuL reduced biofilm formation by the isolates Sa and Ssp5D. However, CasuL‐tetracycline and CasuL‐ampicillin combinations inhibited biofilm formation by Ssp6PD and Ssp01, respectively. In conclusion, CasuL is a bacteriostatic and antibiofilm agent against some mastitis isolates and displayed a synergistic potential when used in combination with either ampicillin (against one isolate) or tetracycline (against two isolates). The results stimulate the evaluation of CasuL for the treatment of mastitis, particularly when used in conjunction with antibiotics.